Posts With Tag Vaccine Development

AstraZeneca PLC commits $2.5 billion to establish a global R&D center in Beijing, enhancing local biotech partnerships and expanding its workforce to 1,700 to advance life sciences.

Discover Sanofi's latest 6-K report, filed on February 13, 2025, detailing progress on an E. coli vaccine study. Stay informed on regulatory compliance and R&D efforts.

Discover Evaxion Biotech A/S's latest Form 6-K report detailing debt conversion strategies and compliance efforts. Stay informed on AI-Immunology™ advancements and investor relations.